Year None2023202220212020201920182017 Jan 9 FDA Advisory Committee Provides Guidance on EYLEA® (aflibercept) Injection as a New Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) 156.2 KB
FDA Advisory Committee Provides Guidance on EYLEA® (aflibercept) Injection as a New Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) 156.2 KB